Skip to main content
. 2013 Spring;12(2):425–434.

Table 2.

Effect of glibenclamide and AEBI on body weight in normal and diabetic rats

Group (n = 6) Treatment Dose (mg/Kg) Average body weight (g)
Week 0 Week 2 Week 4 Week 6
1 N+C 10 mL/Kg 193.20 ± 6.58 211.56 ± 4.74 233.34 ± 3.20** 247.62 ± 1.87**
2 N+AEBI 250 204.08 ± 6.03 216.28 ± 5.22 226.90 ± 4.78 236.78 ± 3.58**
3 N+AEBI 500 200.94 ± 3.47 210.20 ± 2.91 219.76 ± 3.34 236.86 ± 3.18**
4 N+G 0.6 197.86 ± 6.20 212.32 ± 4.41 223.64 ± 4.02* 238.80 ± 2.41**
5 D+C 10 mL/Kg 206.84 ± 3.35 155.28 ± 4.97#** 144.90 ± 2.01#** 137.98 ± 2.24#**
6 D+AEBI 250 195.04 ± 4.67 183.44 ± 2.88d 180.96 ± 3.74d 187.56 ± 3.73d
7 D+AEBI 500 194.36 ± 1.78 181.90 ± 1.62d 183.52 ± 5.97d 200.22 ± 2.78d
8 D+G 0.6 199.94 ± 1.72 184.30 ± 4.08d 193.46 ± 5.53d 203.52 ± 5.61d

AEBI: Aqueous extract of Berberis integerrima; N: normal; C: control; G: glibenclamide; D: diabetic; Values are presented as mean ± SEM. n = 6 in each group. One way ANOVA followed by Tukey test. a p < 0.05 and bp < 0.01 Normal treated rats were compared with Normal control rats. #p < 0.01 Diabetic control rats were compared with Normal control Rats. cp < 0.05 and dp < 0.01 Diabetic treated rats were compared with Diabetic control Rats on corresponding day;*p < 0.05 and**p < 0.01 compared to 0 value